Gradual release of immunotherapy at site of tumor surgery. Mouse study.
Posted: Fri Apr 27, 2018 5:27 pm
I saw this around a moth ago. I think it was in asps facebook group, but could have been somewhere else as well. It just hit me why this might be interesting for asps community, if they ever start to test this in asps. First of all asps main treatment is surgery. Immunotherapies also seems to work well in asps . Nobody knows why at the moment. Surgery indeed forces immunesystem to focus on found healing and this new approach might in theory prevent rebound effect after surgery. Also this is not pd1-inhibitor, so trying it, shouldnt prevent keytruda treatment in the future if neccessery. If my memory serves me correcty dendritic cell vaccine wasnt very succesfull, but this is different approach that might achieve different result. Main reason why I post this, is because if they ever start to test this in asps I want to be able to say, that I believed it was a good idea. If this fails or leads to nowhere then this is just one more stubid thing that I posted on the internet. Allhttp://www.dana-farber.org/newsroom/news-relea ... use-study/ Gradual release of immunotherapy at site of tumor surgery prevents tumors from returning and eliminates cancer spread in mouse study